143 related articles for article (PubMed ID: 15299452)
21. Crystal structure of Saccharomyces cerevisiae 6-phosphogluconate dehydrogenase Gnd1.
He W; Wang Y; Liu W; Zhou CZ
BMC Struct Biol; 2007 Jun; 7():38. PubMed ID: 17570834
[TBL] [Abstract][Full Text] [Related]
22. Structural consequences of hen egg-white lysozyme orthorhombic crystal growth in a high magnetic field: validation of X-ray diffraction intensity, conformational energy searching and quantitative analysis of B factors and mosaicity.
Saijo S; Yamada Y; Sato T; Tanaka N; Matsui T; Sazaki G; Nakajima K; Matsuura Y
Acta Crystallogr D Biol Crystallogr; 2005 Mar; 61(Pt 3):207-17. PubMed ID: 15735330
[TBL] [Abstract][Full Text] [Related]
23. Structure of human erythrocyte NADH-cytochrome b5 reductase.
Bando S; Takano T; Yubisui T; Shirabe K; Takeshita M; Nakagawa A
Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):1929-34. PubMed ID: 15502298
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
25. High-resolution structures of oxidized and reduced thioredoxin reductase from Helicobacter pylori.
Gustafsson TN; Sandalova T; Lu J; Holmgren A; Schneider G
Acta Crystallogr D Biol Crystallogr; 2007 Jul; 63(Pt 7):833-43. PubMed ID: 17582174
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of vestitone reductase from alfalfa (Medicago sativa L.).
Shao H; Dixon RA; Wang X
J Mol Biol; 2007 May; 369(1):265-76. PubMed ID: 17433362
[TBL] [Abstract][Full Text] [Related]
27. The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis.
Fritz-Wolf K; Urig S; Becker K
J Mol Biol; 2007 Jun; 370(1):116-27. PubMed ID: 17512005
[TBL] [Abstract][Full Text] [Related]
28. Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead.
Chan C; Yin H; McKie JH; Fairlamb AH; Douglas KT
Amino Acids; 2002 Jun; 22(4):297-308. PubMed ID: 12107758
[TBL] [Abstract][Full Text] [Related]
29. Structure of human diferric lactoferrin refined at 2.2 A resolution.
Haridas M; Anderson BF; Baker EN
Acta Crystallogr D Biol Crystallogr; 1995 Sep; 51(Pt 5):629-46. PubMed ID: 15299793
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of N-acetyl-gamma-glutamyl-phosphate reductase from Mycobacterium tuberculosis in complex with NADP(+).
Cherney LT; Cherney MM; Garen CR; Niu C; Moradian F; James MN
J Mol Biol; 2007 Apr; 367(5):1357-69. PubMed ID: 17316682
[TBL] [Abstract][Full Text] [Related]
31. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum.
Venkatesan SK; Shukla AK; Dubey VK
J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105
[TBL] [Abstract][Full Text] [Related]
32. Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata.
Henderson GB; Fairlamb AH; Ulrich P; Cerami A
Biochemistry; 1987 Jun; 26(11):3023-7. PubMed ID: 3607007
[TBL] [Abstract][Full Text] [Related]
33. Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductase.
Angelucci F; Miele AE; Boumis G; Dimastrogiovanni D; Brunori M; Bellelli A
Proteins; 2008 Aug; 72(3):936-45. PubMed ID: 18300227
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals.
Cunningham ML; Zvelebil MJ; Fairlamb AH
Eur J Biochem; 1994 Apr; 221(1):285-95. PubMed ID: 8168518
[TBL] [Abstract][Full Text] [Related]
35. Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain.
Untucht-Grau R; Schirmer RH; Schirmer I; Krauth-Siegel RL
Eur J Biochem; 1981 Nov; 120(2):407-19. PubMed ID: 7032915
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Crithidia fasciculata trypanothione reductase and crystallization using a novel geometry.
Strickland CL; Puchalski R; Savvides SN; Karplus PA
Acta Crystallogr D Biol Crystallogr; 1995 May; 51(Pt 3):337-41. PubMed ID: 15299300
[TBL] [Abstract][Full Text] [Related]
37. 2.0 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with a peptide inhibitor and detergent.
Knighton DR; Bell SM; Zheng J; Ten Eyck LF; Xuong NH; Taylor SS; Sowadski JM
Acta Crystallogr D Biol Crystallogr; 1993 May; 49(Pt 3):357-61. PubMed ID: 15299526
[TBL] [Abstract][Full Text] [Related]
38. Toxoplasma gondii ferredoxin-NADP+ reductase: Role of ionic interactions in stabilization of native conformation and structural cooperativity.
Singh K; Bhakuni V
Proteins; 2008 Jun; 71(4):1879-88. PubMed ID: 18175327
[TBL] [Abstract][Full Text] [Related]
39. Structure of the detoxification catalyst mercuric ion reductase from Bacillus sp. strain RC607.
Schiering N; Kabsch W; Moore MJ; Distefano MD; Walsh CT; Pai EF
Nature; 1991 Jul; 352(6331):168-72. PubMed ID: 2067577
[TBL] [Abstract][Full Text] [Related]
40. Cloning and expression of trypanothione reductase from a New World Leishmania species.
Castro-Pinto DB; Genestra M; Menezes GB; Waghabi M; Gonçalves A; De Nigris Del Cistia C; Sant'Anna CM; Leon LL; Mendonça-Lima L
Arch Microbiol; 2008 Apr; 189(4):375-84. PubMed ID: 18060667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
